Rybrevant 350 mg concentrate for solution for infusion


Concetrate for Solution for infusion
scheduling status
S4
registration number
57/30.2/0435
What Rybrevant 350 mg concentrate for solution for infusion contains
Amivantamab.
other ingredients
Ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate L-Histidine L-Histidine hydrochloride monohydrate L-Methionine Polysorbate 80 Sucrose Water for Injection.
Therapeutic classification
A 30.2 Antibodies.
© 2026 SAHPRA. ALL RIGHTS RESERVED